<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">DENILEUKIN DIFTITOX</span><br/>(den-i-leu'kin dif'ti-tox)<br/><span class="topboxtradename">Ontak<br/></span><b>Classifications:</b> <span class="classification">antineoplastic</span>; <span class="classification">interleukin-2 (il-2) inhibitor</span>; <span class="classification">immunomodulator</span><br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>300 mcg/2 mL vial</p>
<h1><a name="action">Actions</a></h1>
<p>A recombinant DNA cytotoxic protein which is an interleukin-2 receptor-specific protein that acts as an antineoplastic agent
         against malignant cells that express the CD25 component of the interleukin-2 (IL-2) receptor on the cell surface.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Effectiveness is indicated by reduced tumor burden. Interacts with high affinity to CD25 IL-2 receptors on the cell surface
         in certain leukemias and lymphomas, thus inhibiting cellular protein synthesis and resulting in cell death in malignant tumors.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Persistent or recurrent T-cell lymphoma.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to denileukin, diphtheria toxin, or interleukin-2; pregnancy (category C), lactation.</p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Cardiovascular disease; hepatic and renal impairment, preexisting lower of serum albumin levels, serum albumin levels below
         3 g/dL. Safety and efficacy in children 
      </p><h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">T-Cell Lymphoma</span><br/><span class="rdage">Adult:</span> <span class="rdroute">IV</span> 9 or 18 mcg/kg/d infused over at least 15 min daily for 5 d every 21 d<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1>
<table cellpadding="4" cellspacing="0" class="ivbox" width="100%">
<tr>
<td><span class="ivtitle">Intravenous</span><p><span class="routemethod">PREPARE:</span> <span class="methodtype">IV Infusion:</span> Bring vials to room temperature (solution will be clear when room temperature is reached). Swirl to mix, but do not shake.
                  Use only plastic syringe and plastic IV bag. Withdraw the calculated dose and inject it into an <u>empty</u> IV bag. Add <small>NO MORE THAN</small> 9 mL sterile saline without preservative to IV bag for each 1 mL of drug. Use within 6 h of preparation.  
               </p>
<p><span class="routemethod">ADMINISTER:</span> <span class="methodtype">IV Infusion:</span> Infuse over <u>at least</u> 15 min without an in-line filter. Stop infusion and notify physician if S&amp;S of hypersensitivity occur.  
               </p>
<p><span class="routemethod">INCOMPATIBILITIES</span> <span class="incompattype"> Solution/additive:</span> Do not physically mix with any other drug. 
               </p>
</td>
</tr>
</table>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">Body as a Whole:</span>
<span class="speceff-common">Chills, fever, asthenia, infection, pain, headache, chest pain,</span> flu-like syndrome; injection site reaction; <span class="speceff-common">acute hypersensitivity reaction (hypotension, back pain, dyspnea, vasodilation, rash, chest pain or tightness, tachycardia,
         dysphagia, syncope,</span>
<span class="speceff-both">anaphylaxis)</span>, myalgia, arthralgia. <span class="typehead">CNS:</span>
<span class="speceff-common">Dizziness, paresthesia, nervousness,</span> confusion, insomnia. <span class="typehead">CV:</span>
<span class="speceff-common">Vascular leak syndrome (hypotension, edema, hypoalbuminemia); hypotension, vasodilation, tachycardia,</span> thrombotic events, hypertension, arrhythmia. <span class="typehead">GI:</span>
<span class="speceff-common">Nausea, vomiting, anorexia, diarrhea,</span> constipation, dyspepsia, dysphagia. <span class="typehead">Hematologic:</span>
<span class="speceff-common">Anemia,</span> thrombocytopenia, leukopenia. <span class="typehead">Metabolic:</span>
<span class="speceff-common">Hypoalbuminemia; transaminase increase; edema; hypocalcemia; weight loss;</span> dehydration; hypokalemia. <span class="typehead">Respiratory:</span>
<span class="speceff-common">Dyspnea, cough, pharyngitis, rhinitis,</span> lung disorder.  <span class="typehead">Skin:</span>
<span class="speceff-common">Rash, pruritus, sweating.</span>
<span class="typehead">Urogenital:</span>
<span class="speceff-common">Hematuria, albuminuria, pyuria, increased creatinine.</span>
<h1><a name="interactions">Interactions</a></h1>No clinically significant interactions established. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Distribution:</span> Primarily distributed to liver and kidneys. <span class="typehead">Metabolism:</span> Metabolized by proteolytic degradation.  <span class="typehead">Half-Life:</span> 7080 min. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor and notify physician immediately for S&amp;S of hypersensitivity or anaphylaxis that occur during/within 24 h of infusion.</li>
<li>Monitor and notify physician immediately for S&amp;S of flu-like syndrome that occur within several hours to days following infusion.</li>
<li>Monitor outpatients for weight gain, developing edema, or declining blood pressure. Notify physician immediately for S&amp;S of
            vascular leak syndrome (e.g., edema PLUS hypotension or hypoalbuminemia) that may occur within 2 wk of infusion.
         </li>
<li>Lab tests: Baseline and weekly CBC with differential, platelet count, blood chemistry panel (including serum electrolytes,
            serum albumin, renal and liver functions).
         </li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Report S&amp;S of infection promptly to physician.</li>
<li>Check weight daily and report rapid weight gain or swelling of extremities promptly.</li>
<li>Report bothersome adverse effects or S&amp;S of infection or flu-like symptoms (e.g., fever, nausea, vomiting, diarrhea, rash).</li>
<li>Do not breast feed while taking this drug.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>